Critics Say CDC Advisors' Infection Control Guidance Isn't Strong Enough

[MEDPAGE TODAY]( Daily Headlines Monday, November 06, 2023 Today's Top Stories for {NAME} [SPECIAL REPORTS]( [Critics Say CDC Advisors' Infection Control Guidance Isn't Strong Enough]( [MEETING COVERAGE]( [Novel Aldosterone Synthase Inhibitor Cuts Albuminuria in Phase II Trial]( [ANESTHESIOLOGY]( [Heart Injuries Suggest Reconsideration of Holding BP Meds for Surgery]( THE BREAK ROOM [Wordectomy: Guess Today’s Medical Condition]( CME SPOTLIGHT [Applying the Latest Clinical Evidence to Treatment Plans for Pediatric Patients With Hodgkin Lymphoma]( [NEUROLOGY]( [Blood Test Detects MS Disability Worsening a Year Before It Occurs]( [NURSING]( [Former Nurse Sees Raft of New Charges in Murder Investigation]( THE BREAK ROOM [Play Today’s Wordosis]( ADVERTISEMENT [POP MEDICINE]( [How Dangerous Is Caffeine for People With Severe Arrhythmias?]( CME SPOTLIGHT [Advancing Care of Patients With Sickle Cell Disease]( [MEETING COVERAGE]( [Mixed Results for Tiragolumab/Atezolizumab Combo in PD-L1+ Recurrent Cervical Cancer]( [PEDIATRICS]( [Foster Care Admission Surged When Abortion Access Fell, Study Shows]( [MEETING COVERAGE]( [VEGF-Targeted Antibody Conjugate Gets a Win in Nonproliferative Diabetic Retinopathy]( CME SPOTLIGHT [CAR T-Cell Therapy 101]( [MEETING COVERAGE]( [GLP-1 Receptor Agonists Help With Weight Loss for HIV Patients]( [MEETING COVERAGE]( [Kidney Transplant Rates Stubbornly Resist Systems Intervention in Canada]( [MEETING COVERAGE]( [Should the Way We Describe MS Progression Change?]( CME SPOTLIGHT [Individualizing von Willebrand Disease Treatment Strategies for Patients With Severe and Frequent Bleeds]( [MEETING COVERAGE]( [Gene Therapy Controls Diabetic Eye Disease for at Least a Year]( [OPINION]( [Why Aren't We Treating Health Disparities Like the Crises They Are?]( [SPOTLIGHT ON]( [What's on the Horizon for Myasthenia Gravis]( CME SPOTLIGHT [Amplifying New and Emerging Clinical Evidence in the Treatment and Management of Myelodysplastic Syndrome]( [VIDEO]( [Transitioning Patients With Atopic Dermatitis From Topical to Systemic Therapy]( [OPINION]( [Want Your Patients to be More Independent? The Answer is Simple: More Simplicity]( [ASCO READING ROOM]( [Best Treatment for Nonseminomatous Testicular Cancer With Viable Tumor Cells at Post-Chemo RPLND?]( CME SPOTLIGHT [Accelerating Adoption of Novel Therapies for Optimal Diffuse Large B-Cell Lymphoma Care]( [MEETING COVERAGE]( [Sparsentan Bests Irbesartan for Preserving Kidney Function in IgA Nephropathy]( [MEETING COVERAGE]( [RAF/MEK and FAK Inhibitor Combo Effective in Low-Grade Serous Ovarian Cancer]( [MEETING COVERAGE]( [Maintenance Selinexor May Boost PFS in TP53 Wild-Type Advanced Endometrial Cancer]( [MEETING COVERAGE]( [Eye Drops Make Bid for Role in Diabetic Macular Edema]( # Weekly Survey [Concerned About Gene-Editing Therapies?]( FDA advisors [appeared convinced]( that the benefits of a novel CRISPR therapy for sickle cell disease outweigh the theoretical risks for off-target gene editing[VOTE >]( Meeting Coverage Can't get away? MedPage Today brings you extensive coverage of more than 80 meetings in a wide range of specialties. [SEE ALL STORIES >]( Got a news tip? MedPage Today offers several ways to provide information to our journalists securely and confidentially. [LEARN MORE >]( [EVERYDAY HEALTH]( © 2023 MedPage Today, LLC. MedPage Today is among the federally registered trademarks of MedPage Today, LLC, and may not be used by third parties without explicit permission. You have received this email because you have registered to receive emails at www.medpagetoday.com, with the email address: {EMAIL} [Manage Email Preferences]( | [Unsubscribe](lst=NL_Daily_DHE?xid=nl_mpt_DHE_2023-11-06&eun=g1020308d0r) | [Terms of Use]( | [Privacy Policy]( Technical Questions: feedback@medpagetoday.com 114 5th Avenue, 15th Floor New York, NY 10011